COMMUNIQUÉS West-GlobeNewswire

Rakovina Therapeutics Announces Appointment of New Scientific Advisory Board Member
17/09/2026
Yale physician-scientist and biotech entrepreneur Dr. Ranjit Bindra brings deep expertise in DNA repair, synthetic lethality and brain tumor therapeutics VANCOUVER, British Columbia, Sept. 17, 2026 (GLOBE NEWSWIRE) -- [...]
SNIPR enrolls first patient in Phase 2 portion of SNIPR001 trial, expanding study to 66 patients
17/09/2026
COPENHAGEN, Denmark, Sept. 17, 2026 (GLOBE NEWSWIRE) -- SNIPR today announced that the first patient has been enrolled in Part 2 of the Phase 1b/2a clinical trial of SNIPR001 (NCT06938867), the Company's lead CRISPR- [...]
RAMSAY SANTE Group unveils "Connecting Care 2030"
17/09/2026
PRESS RELEASE Paris, 17 September 2026 Ramsay Santé Group unveils “Connecting Care 2030” to drive next phase of profitable growth and create long term value for all stakeholders “Connecting Care 2030”, Ramsay Santé [...]
Le Groupe RAMSAY SANTE dévoile "Connecting Care 2030"
17/09/2026
COMMUNIQUÉ DE PRESSE Paris, le 17 septembre 2026 Le groupe Ramsay Santé dévoile « Connecting Care 2030 », pour accélérer sa croissance rentable et créer de la valeur durable pour l’ensemble de ses parties prenantes « [...]
Tarja Stenvall Appointed Chief Executive Officer of Bavarian Nordic
17/09/2026
COPENHAGEN, Denmark, September 17, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that Tarja Stenvall has been appointed President and Chief Executive Officer, effective October 15, 2026, succeeding Paul Chaplin [...]
Boehringer Ingelheim launches PED Essentials, an online learning resource that gives patients a stronger voice
17/09/2026
Patient experience data (PED) are direct insights that patients provide on their symptoms, quality of life, treatment preferences and unmet needs. PED Essentials is an online learning hub, co-created with patients and [...]
Roche’s Lunsumio-based regimen significantly improves progression-free survival in follicular lymphoma in phase III CELESTIMO study
17/09/2026
Phase III CELESTIMO study met its primary endpoint at the interim analysis demonstrating a statistically significant and clinically meaningful reduction in the risk of disease progression in people with follicular [...]
Desert Hope Treatment Center Names Blaise Schafer Lead Clinician for New First Responders Program
17/09/2026
LAS VEGAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Desert Hope Treatment Center has named Blaise Schafer, LCSW, lead clinician for its new First Responders Program at its residential treatment facility in Las Vegas. The [...]
MEDVi QUAD Formula Update Confirmed for 2026: Apomorphine Replaces PT-141 in Current 4-in-1 Combination
17/09/2026
Sildenafil, Tadalafil, Apomorphine, and L-Citrulline Confirmed as MEDVi's Current QUAD Formulation for Compounded ED Treatment Newark, DE, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Compounded medications are not FDA-approved [...]
AdCare Hospital Promotes Lilly Cabral to Role of Clinical Director
17/09/2026
WORCESTER, Mass., Sept. 16, 2026 (GLOBE NEWSWIRE) -- AdCare Hospital, a leading provider of medical detox and addiction treatment services in Worcester, MA, has appointed Lilly Cabral, M.A., LADC-I, as the Clinical [...]
COSCIENS COMPLETES SECOND TRANCHE OF CONVERTIBLE DEBENTURE OFFERING
17/09/2026
TORONTO, ONTARIO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“ COSCIENS ” or the “ Company ”) is pleased to announce, further to the press release dated September 10, 2026, [...]
Teknova Expands Custom Manufacturing with Fill-Tek™ Dispensing System for Flexible Single-Use Bag Filling
16/09/2026
Available now, this new proprietary dispensing capability lets customers order the exact single-use bag sizes and quantities their process requires, released as a single lot with one Certificate of Analysis, with no [...]
Longeveron Announces Topline Results from ELPIS II Phase 2b Clinical Trial Evaluating Laromestrocel as a Potential Treatment for Hypoplastic Left Heart Syndrome (HLHS)
16/09/2026
Company Announces Exploration of All Options to Maximize Shareholder Value The top line results showed that the ELPIS II trial did not meet its primary endpoint of improvement in right ventricular ejection fraction ( [...]
Flow Neuroscience launches FL-100 in the US, the first FDA-approved at-home tDCS treatment for depression
16/09/2026
Malmö, Sweden, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Prescription-only treatment gives clinicians a new way to treat eligible adults with moderate to severe major depressive disorder at home, either as a standalone [...]
Roto-Rooter Buys Largest Franchisee Territory
16/09/2026
CINCINNATI, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Roto-Rooter Services Company , a wholly owned subsidiary of Chemed Corporation ("Chemed") (NYSE: CHE ) announced it has acquired the largest independent Roto-Rooter [...]
Braveheart Bio to Participate in Stifel Cardiometabolic Forum
16/09/2026
SAN FRANCISCO, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Braveheart Bio, Inc. (Nasdaq: BRVE), a clinical-stage biopharmaceutical company developing next-generation therapeutics for hypertrophic cardiomyopathy (HCM) and other [...]
Pennant Acquires Real Estate of Mainplace Senior Living in Orange, California
16/09/2026
EAGLE, Idaho, Sept. 16, 2026 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of Pennant affiliated home health, hospice, home care and senior living companies, announced today that, [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
16/09/2026
Greenville, South Carolina, Sept. 16, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that David Keys has resigned as a member of the Company’s Board of Directors effective [...]
Spectral AI Showcases DeepView® System for Burn Indication and KOL Research at Southern Regional Burn Conference
16/09/2026
Announces Upcoming Burn Conference Schedule DALLAS, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”) , an artificial intelligence (AI) company focused on medical [...]

Pages